Navigation Links
Moffitt, Sanford-Burnham and Florida Hospital create Personalized Medicine Partnership of Florida

TAMPA, Fla. and ORLANDO, Fla. Moffitt Cancer Center, Sanford-Burnham Medical Research Institute and Florida Hospital have announced they will collaborate on the creation of a Personalized Medicine Partnership of Florida (PMP Florida). The partnership will conduct collaborative research to accelerate discovery and develop new treatments in the areas of cancer and metabolic diseases, including obesity, diabetes and cardiovascular disease.

PMP Florida will revolutionize health care by creating partnerships among Florida-based centers of excellence in medical research and clinical care. Together, the organizations will develop and utilize new molecular and genomic technologies to discover, translate and personalize interventions for preventing and treating debilitating diseases more efficiently to improve health care outcomes while reducing costs.

PMP Florida will leverage Moffitt's Total Cancer Care to develop similar research and clinical protocols in other disease areas including metabolic diseases. The partnership will hasten the discovery and development of new treatments by bringing together the complementary strengths of Florida Hospital's large patient population and clinical research expertise; Sanford-Burnham's fundamental research expertise and technology platforms; and Moffitt's biospecimen bank, data warehouse and personalized medicine capabilities.

"As a statewide resource for cancer research and treatment Moffitt seeks to foster relationships such as these to maximize the state's investment in the overall health and well-being of patients," said William S. Dalton, Ph.D., M.D., CEO and center director of Moffitt. "We feel this partnership will enhance Florida's national and international reputation in the discovery, translation, delivery and dissemination of care."

Total Cancer Care is a treatment path that begins by mapping the more than 30,000 genes that make up a tumor to find its own unique genetic fingerprint. Through personalized medicine, Moffitt is working to create individualized therapies that are specific to each patient's type of cancer, and the way each person responds to the disease and treatment therapies. The approach includes medical, nutritional, psychological, social and physical considerations.

Collaborations between research and clinical organizations are increasing as a means to access complementary resources, attract more sizable grant revenues and enhance the translation of laboratory research to clinical application.

"PMP Florida is a multi-institutional model for combining research and clinical care expertise to advance personalized medical care. Sanford-Burnham will deploy our most advanced technologies to discover molecular signatures of disease that can provide insight for determining appropriate therapeutic interventions," said John C. Reed, MD, Ph.D., and CEO, Sanford-Burnham Medical Research Institute. "The technology platforms, collections of patient samples, and medical information sharing create a powerful combination for improving clinical outcomes and reducing health care costs."

Through PMP Florida, researchers at the partnering institutions will access a robust research and clinical care infrastructure. Bio-samples representing a variety of diseases will be derived from Florida Hospital's expansive patient population. Pilot projects will utilize Moffitt's genome mapping, information systems and clinical research protocols developed through Total Cancer Care. The research will be empowered by Sanford-Burnham's scientific expertise in genomics and metabolomics technology platforms.

"PMP Florida is a unique partnership including three organizations with very complementary areas of expertise and experience," said Dr. David Moorhead, senior vice president and chief medical officer at Florida Hospital. "Moffitt has demonstrated world class experience and competency in acquiring, categorizing and storing biologic specimens. Sanford-Burnham Medical Research Institute is renowned for its internationally recognized scientific faculty, multiple sophisticated diagnostic platforms and a commitment to transforming basic science research into clinically available treatments. Florida Hospital is the largest hospital in Florida with broad, innovative and superior clinical expertise. Together, our organizations will have the potential to quickly and successfully advance the scientific development and availability of personalized medicine and to benefit the economic development of our communities."

One of the objectives of the partnership is to attract industry clients, including pharmaceutical and biotech companies, who will want to utilize this unique resource for discovery and development of new advances in health care. This partnership will exemplify how personalized medicine discoveries made in research labs will improve health care in hospitals, clinics and medical offices in Florida and nationally.

Contact: Deborah Robison
Sanford-Burnham Medical Research Institute

Related medicine news :

1. Dana-Farber and Sanford-Burnham Institute license flu-targeting antibodies to Genentech and Roche
2. Dr. Kristiina Vuori Promoted to President of Sanford-Burnham Medical Research Institute
3. Scripps Health and Sanford-Burnham to collaborate to advance new cancer treatments
4. Sanford-Burnham researchers find molecular switch that allows melanoma to resist therapy
5. Homebuyers Celebrate Grand Opening of New Homes in Fort Myers, Florida with G.L. Homes
6. Tired of Snow, Sleet, and Stress? Join Deepak Chopra for a Week-Long Meditation Retreat this March in Florida's Warm Sunshine
7. DavisPTnetwork Partners with the Florida Physical Therapy Association to Provide Online Continuing Education
8. Pew Report: Florida Failing To Address Childrens Dental Health Crisis
9. Diabetics Twice as Likely to Have Hearing Loss; Florida HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March
10. Truth-O-Meter™ Comes to Florida: St. Petersburg Times, The Miami Herald Launch PolitiFact Florida
11. AMA Honors Florida Senator Don Gaetz With Top Government Service Award
Post Your Comments:
(Date:11/25/2015)... ... ... “While riding the bus, I saw a passenger in a wheelchair drenched from ... a convenient and comfortable way to protect them from bad weather, so I invented ... during cold or inclement weather. In doing so, it ensures that the user remains ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination ... in a way for homeless people to have a more dignified and comfortable ... initiative whereby they are repurposing plastic bags into sleeping mats for the homeless. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... focused on providing comprehensive solutions involving adult stem cell therapies to patients with ... deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology: